Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930413-05-004164
Filing Date
2005-06-06
Accepted
2005-06-06 17:16:19
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 c37767_10k-a.txt 10-K/A 301324
2 c37767_ex10-12.txt EX-10.12 44530
3 c37767_ex10-13.txt EX-10.13 45927
4 c37767_ex10-14.txt EX-10.14 23419
5 c37767_ex10-15.txt EX-10.15 3176
6 c37767_ex23.txt EX-23 658
7 c37767_ex31-1.txt EX-31.1 4298
8 c37767_ex31-2.txt EX-31.2 4304
9 c37767_ex32-1.txt EX-32.1 1448
10 c37767_ex32-2.txt EX-32.2 1453
  Complete submission text file 0000930413-05-004164.txt   432110
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32325 | Film No.: 05881160
SIC: 2834 Pharmaceutical Preparations